|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Ember Therapeutics Expands Scientific Leadership to Advance Metabolic Pipeline
5/30/2012 9:56:52 AM
BOSTON--(BUSINESS WIRE)--Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the appointment of Jasbir Seehra, Ph.D., to chief scientific officer; also, Jeff Saunders, Ph.D., joins Ember as vice president, small molecule drug discovery. Drs. Seehra and Saunders will advance the company’s work in translating its world-class biology into a proprietary pipeline of groundbreaking therapies for metabolic diseases, including Type 2 diabetes and obesity.
|
|
|
|
|
|
|
|
|
|
|